Tanner Pharma Group signs distribution agreement with Nephcentric LLC

Tanner Pharma Group (“Tanner”), a global provider of integrated specialty access solutions, has announced the signing of a distribution agreement with Nephcentric LLC (“Nephcentric”), a developer and marketer of evidence based therapeutic options for people with kidney disease and metabolic disorders. The agreement names Tanner as a distributor of urea 15g in areas outside of the United States, Canada, and the Middle East where the product is not yet registered. Urea 15 g is a Medical Food for the management of hyponatremia.

The distribution will be managed by TannerGAP, Inc. (“TannerGAP”), a wholly owned subsidiary of Tanner Pharma Group. TannerGAP offers turn key global access solutions for the distribution of products from markets of supply to markets of demand.

We are excited to work with Nephcentric on a global level to provide urea 15g access to patients in need."

Maryori Alvarenga, Managing Director of US and Global Director for TannerGAP

We are looking forward to our partnership with Tanner to help expand our reach beyond North America. Our partnership with Tanner will help more patients in need gain access to our cost-effective, evidence-based therapeutic options."

Caroline Von Scheven, Operations Lead for Nephcentric

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Tanner Pharma Group. (2019, August 29). Tanner Pharma Group signs distribution agreement with Nephcentric LLC. News-Medical. Retrieved on November 02, 2024 from https://www.news-medical.net/news/20190829/Tanner-Pharma-Group-signs-distribution-agreement-with-Nephcentric-LLC.aspx.

  • MLA

    Tanner Pharma Group. "Tanner Pharma Group signs distribution agreement with Nephcentric LLC". News-Medical. 02 November 2024. <https://www.news-medical.net/news/20190829/Tanner-Pharma-Group-signs-distribution-agreement-with-Nephcentric-LLC.aspx>.

  • Chicago

    Tanner Pharma Group. "Tanner Pharma Group signs distribution agreement with Nephcentric LLC". News-Medical. https://www.news-medical.net/news/20190829/Tanner-Pharma-Group-signs-distribution-agreement-with-Nephcentric-LLC.aspx. (accessed November 02, 2024).

  • Harvard

    Tanner Pharma Group. 2019. Tanner Pharma Group signs distribution agreement with Nephcentric LLC. News-Medical, viewed 02 November 2024, https://www.news-medical.net/news/20190829/Tanner-Pharma-Group-signs-distribution-agreement-with-Nephcentric-LLC.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Tanner Pharma Group signs a distribution agreement for partner therapeutics’ product